In a recent interview with CNBC at the Web Summit in Lisbon, Oura CEO Tom Hale outlined an ambitious forecast for the Finnish wearables company. With an upgraded outlook following a $900 million funding round in October, Oura now expects nearly $2 billion in sales in the upcoming fiscal year.
Strategic Growth And International Expansion
Oura, valued at $11 billion, has experienced rapid growth in recent years. Hale emphasized that the company’s robust performance is largely attributable to its successful market entry with health features tailored to women and its aggressive international expansion strategy. With revenue on track to hit $1 billion in 2025—doubling the 2024 figures—Oura’s revised forecast represents a significant upward adjustment from the previously reported sales projection of over $1.5 billion. Industry observers are closely monitoring these developments as a marker of the company’s aggressive growth trajectory.
Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram
Leveraging Artificial Intelligence For Preventative Health
Hale described Oura’s integration of artificial intelligence as a core component of its strategy. The company not only offers insights based on wearable data but also employs AI to transform metrics into actionable advice and coaching. The inclusion of the Oura Advisor—a chatbot that acts like a personal doctor—underscores the company’s commitment to delivering personalized, preventative healthcare solutions.
Innovative Partnerships Enhancing Product Capabilities
Oura’s relentless pursuit of innovation is highlighted by its recent partnerships. In 2022, the company joined forces with Natural Cycles to integrate fertility features, building on its established reputation. More recently, collaborations have enabled the addition of glucose monitoring through a partnership with Dexcom (read more), and the company announced new blood pressure research (details here). These strategic moves position Oura as a comprehensive guardian for long-term health—a role that continues to drive its sales performance as it nears a landmark of 5.5 million rings sold since 2015.
Looking To The Future
Despite these bold ambitions and breakthrough innovations, Hale confirmed that there are no immediate plans for an IPO. Instead, the focus remains on leveraging technological advancements such as AI to further cement Oura’s stature in the global wearable tech market.
As Oura continues to blend cutting-edge technology with health and wellness, the company’s forward-looking strategy not only signifies its capacity to achieve near $2 billion in sales but also reflects a broader trend where tech and healthcare converge to deliver personalized benefits to consumers.
